Parnell Pharmaceuticals PARNF Stock
Parnell Pharmaceuticals Price Chart
Parnell Pharmaceuticals PARNF Financial and Trading Overview
| Parnell Pharmaceuticals stock price | 0.08 USD |
| Previous Close | 0.0003 USD |
| Open | 0.0003 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.0003 - 0.0003 USD |
| 52 Week Range | 0.0003 - 0.0026 USD |
| Volume | 10.8K USD |
| Avg. Volume | 305 USD |
| Market Cap | 2.87M USD |
| Beta (5Y Monthly) | 1.33169 |
| PE Ratio (TTM) | Infinity |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PARNF Valuation Measures
| Enterprise Value | 47.1M USD |
| Trailing P/E | Infinity |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.08391568 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 1.379 |
| Enterprise Value/EBITDA | 7.848 |
Trading Information
Parnell Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 1.33169 |
| 52-Week Change | -85.71% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.0026 USD |
| 52 Week Low | 0.0003 USD |
| 50-Day Moving Average | 0.001796 USD |
| 200-Day Moving Average | 0.0022825 USD |
PARNF Share Statistics
| Avg. Volume (3 month) | 305 USD |
| Avg. Daily Volume (10-Days) | 1.12K USD |
| Shares Outstanding | 18.15M |
| Float | N/A |
| Short Ratio | 0.29 |
| % Held by Insiders | 0% |
| % Held by Institutions | 0% |
| Shares Short | 27.41K |
| Short % of Float | 0.41% |
| Short % of Shares Outstanding | 0.20% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | September 30, 2019 |
| Next Fiscal Year End | December 31, 2022 |
Profitability
| Profit Margin | -4.15% |
| Operating Margin (ttm) | 12.23% |
| Gross Margin | 56.38% |
| EBITDA Margin | 17.56% |
Management Effectiveness
| Return on Assets (ttm) | 6.47% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 34.17M USD |
| Revenue Per Share (ttm) | 1.18 USD |
| Quarterly Revenue Growth (yoy) | 54.40% |
| Gross Profit (ttm) | 19.26M USD |
| EBITDA | 6M USD |
| Net Income Avi to Common (ttm) | -1419593 USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 3.68M USD |
| Total Cash Per Share (mrq) | 0.12 USD |
| Total Debt (mrq) | 50.78M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.981 |
| Book Value Per Share (mrq) | -1.174 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 5.45M USD |
| Levered Free Cash Flow (ttm) | -1057010 USD |
Profile of Parnell Pharmaceuticals
| Country | United States |
| State | NSW |
| City | Alexandria |
| Address | Century Estate |
| ZIP | 2015 |
| Phone | 61 2 9667 4411 |
| Website | https://www.parnell.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Parnell Pharmaceuticals Holdings Ltd, a commercial-stage pharmaceutical company, focuses on developing, manufacturing, and marketing animal pharmaceutical products worldwide. The company operates through four segments: Companion Animal, Production Animal - U.S., Production Animal - Rest of World, and Manufacturing Operations. It markets various products, including estroPLAN and GONAbreed reproductive hormone products for enhancing cattle breeding performance; Zydax for the treatment of osteoarthritis (OA) in dogs and horses; and Glyde, a nutraceutical product for the treatment of OA, as well as Parnell PROcept, which adds an additional injection of estroPLAN after the first injection. The company also offers mySYNCH, a digital tool to help veterinarians and producers optimize reproduction and maximize economic gains. Parnell Pharmaceuticals Holdings Ltd was incorporated in 2009 and is headquartered in Alexandria, Australia.
Q&A For Parnell Pharmaceuticals Stock
What is a current PARNF stock price?
Parnell Pharmaceuticals PARNF stock price today per share is 0.08 USD.
How to purchase Parnell Pharmaceuticals stock?
You can buy PARNF shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Parnell Pharmaceuticals?
The stock symbol or ticker of Parnell Pharmaceuticals is PARNF.
Which industry does the Parnell Pharmaceuticals company belong to?
The Parnell Pharmaceuticals industry is Drug Manufacturers-Specialty & Generic.
How many shares does Parnell Pharmaceuticals have in circulation?
The max supply of Parnell Pharmaceuticals shares is 21.05M.
What is Parnell Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Parnell Pharmaceuticals PE Ratio is now.
What was Parnell Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Parnell Pharmaceuticals EPS is 0 USD over the trailing 12 months.
Which sector does the Parnell Pharmaceuticals company belong to?
The Parnell Pharmaceuticals sector is Healthcare.